Platelet activating factor (PAF) stimulates release of PGI2 from inflamed rabbit gallbladder cell cultures

Prostaglandins
S I MyersB Kalley-Taylor

Abstract

This study examines the hypothesis that PAF stimulates release of PGI2 from inflamed rabbit gallbladder explant cell cultures. New Zealand white rabbits underwent bile duct ligation for 72 h (72 h BDL), or sham operation, Sham and 72 h BDL gallbladder explants were placed in culture, and the cells grown to 75% confluence. The cells were exposed to increasing concentrations of PAF for 60 min. The media analyzed for eicosanoid release by EIA and the cells analyzed for cyclooxygenase and prostacyclin synthase content by immunoblot analysis. PAF increased release of 6-keto-PGF1 alpha from the 72 h BDL gallbladder cell cultures in a dose-related manner which was inhibited by indomethacin preincubation by 90%. The increased 72 h BDL cell release of 6-keto-PGF1 alpha was not associated with changes in the content of cyclooxygenase or prostacyclin synthase. PAF did not alter eicosanoid release from sham control cell cultures. These data suggest that PAF can only up-regulate endogenous 6-keto-PGF1 alpha release from the 72 h BDL cells that had been previously stimulated by inflammation. PAF may thus contribute to gallbladder distention and injury by chronic stimulation of inflamed gallbladder PGI2 release.

References

Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A G StewartG J Dusting
Jan 1, 1990·Methods in Enzymology·P PradellesJ Maclouf
Jun 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D L KaminskiY G Deshpande
Jul 18, 1989·European Journal of Pharmacology·L A O'Neill, G P Lewis
Nov 15, 1989·Biochemical and Biophysical Research Communications·C T EvansP A Srere
Jul 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S GovindarajanR D Zipser
Sep 4, 1984·Journal of Immunological Methods·H Towbin, J Gordon
Aug 1, 1983·Analytical Biochemistry·A L De Blas, H M Cherwinski
Jul 1, 1984·Kidney International·J B LefkowithP Needleman
Dec 1, 1984·The Journal of Clinical Investigation·P J Whiteley, P Needleman
Mar 1, 1984·The Histochemical Journal·M S ElhamadyI A Bouchier
Jul 1, 1983·The Journal of Pathology·M S ElhamadyI A Bouchier
Sep 1, 1993·Molecular and Cellular Endocrinology·S I MyersA Riva

❮ Previous
Next ❯

Citations

Feb 22, 2001·The Journal of Surgical Research·H P ParkmanS I Myers
Jul 18, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·H P ParkmanJ P Ryan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.